Overview
George Kanellis practices in Athens, Greece. Mr. Kanellis is rated as an Advanced expert by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). His top areas of expertise are Primary Mediastinal B-Cell Lymphoma (PMBCL), Splenic Neoplasm, Marginal Zone Lymphoma (MZL), and Non-Hodgkin Lymphoma.
His clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Primary Mediastinal B-Cell Lymphoma (PMBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Marginal Zone Lymphoma (MZL)Mr. Kanellis isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Primary Mediastinal B-Cell Lymphoma (PMBCL)
- Splenic NeoplasmMr. Kanellis isAdvanced. Learn about Splenic Neoplasm.
- Experienced
- B-Cell LymphomaMr. Kanellis isExperienced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Mr. Kanellis isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Kanellis isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Hairy Cell Leukemia (HCL)Mr. Kanellis isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Inflammatory Breast CancerMr. Kanellis isExperienced. Learn about Inflammatory Breast Cancer.
- LeukemiaMr. Kanellis isExperienced. Learn about Leukemia.